Pacira Pharmaceuticals (PCRX) Earnings
|
Expand Research on PCRX
| Next EPS Date | 5/1/24 | EPS Growth Rate | +246.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -55.1% | Revenue Growth Rate | +3.5% |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/11  |
 |
Q410 | -$12.27 | -$0.44 | -$11.83 | $2.2M | $4.16M | = |  | | Details |
| 5/3/23 | Q123 | -$0.43 | $0.61 | -$1.04 | $160.3M | $159.1M | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.02 | $0.81 | -$0.83 | $167.5M | $171.24M | N/A | | | Details | |
| 8/2/23 |
Q223 | N/A | $0.76 | N/A | N/A | $174.86M | N/A | N/A | N/A | ||
| 5/1/24 | Q124 | N/A | $0.63 | N/A | N/A | $165.85M | = | N/A | N/A | ||
| 5/11/11 | Q111 | -$0.98 | -$0.53 | -$0.45 | $3.9M | $4.16M | = | | | Details | |
| 8/3/22 | Q222 | $0.53 | $0.88 | -$0.35 | $169.4M | $172.22M | N/A | | | Details | |
| 2/29/24 | Q423 | $0.54 | $0.88 | -$0.34 | $181.2M | $180.85M | = | | | Details |
